Common use of Research and Development Milestones Clause in Contracts

Research and Development Milestones. for the GI-4000 Program. If Celgene exercises the Celgene Program Option with respect to the GI-4000 Program, in consideration of the research and Development work performed by GlobeImmune under this Agreement for the GI-4000 Program, Celgene shall pay, within thirty (30) days following the date of achievement of each milestone below (or, if achievement of such milestone is within the control of GlobeImmune, within thirty (30) days following Celgene’s receipt of notice of the achievement of such milestone), to GlobeImmune the following milestone payments once each upon the achievement of the designated milestone events. Each payment will be made once regardless of how many Collaboration Compounds in the GI-4000 Program may achieve each milestone event. Milestone Event Payment [*] [* ] [*] [* ] [*] [* ] [*] [* ] [*] [* ] [*] [* ] [*] [* ] [*] [* ] [*] [* ] [*] [* ] [*] [* ] [*] [* ] [*] [* ] [*] [* ] [*] [* ] Total for GI-4000 Program [* ] [*] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. * For purposes of this Section 6.2.2, [*]

Appears in 4 contracts

Samples: Collaboration and Option Agreement (Globeimmune Inc), Collaboration and Option Agreement (Globeimmune Inc), Collaboration and Option Agreement (Globeimmune Inc)

AutoNDA by SimpleDocs

Research and Development Milestones. for the GI-4000 Program. If Celgene exercises the Celgene Program Option with respect to the GI-4000 Program, in consideration of the research and Development work performed by GlobeImmune under this Agreement for the GI-4000 Program, Celgene shall pay, within thirty (30) days following the date of achievement of each milestone below (or, if achievement of such milestone is within the control of GlobeImmune, within thirty (30) days following Celgene’s receipt of notice of the achievement of such milestone), to GlobeImmune the following milestone payments once each upon the achievement of the designated milestone events. Each payment will be made once regardless of how many Collaboration Compounds in the GI-4000 Program may achieve each milestone event. Milestone Event Payment [*] [* ] [*] [* ] [*] [* ] [*] [* ] [*] [* ] [*] [* ] [*] [* ] [*] [* ] [*] [* ] [*] [* ] [*] [* ] [*] [* ] [*] [* ] [*] [* ] [*] [* ] Total for GI-4000 Program [* ] [*] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 406 24b-2 of the Securities Exchange Act of 19331934, as amended. * For purposes of this Section 6.2.2, [*]

Appears in 2 contracts

Samples: Collaboration and Option Agreement (Globeimmune Inc), Collaboration and Option Agreement (Globeimmune Inc)

AutoNDA by SimpleDocs
Time is Money Join Law Insider Premium to draft better contracts faster.